Digital twins revolutionize drug discovery by integrating AI and biological data, enhancing prediction, trial design, and decision-making in precision medicine.
The third phase of Destination Earth (DestinE) was confirmed by the European Commission on 1 February 2026.DestinE is an initiative of the European Commission to build a highly accurate digital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results